Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.260
-0.060 (-2.59%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $207.65 million as of April 24, 2026. Its market cap has increased by 245.49% in one year.
Market Cap
207.65M
Enterprise Value
141.76M
1-Year Change
245.49%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $207.65M, an increase of 306.93%. That is a compound annual growth rate of 36.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 207.65M | 53.74% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Codexis | 228.99M |
| Keros Therapeutics | 227.93M |
| OmniAb | 225.86M |
| Achieve Life Sciences | 220.95M |
| Caribou Biosciences | 218.40M |
| Elicio Therapeutics | 217.99M |
| Enlivex | 215.23M |
| MediWound | 213.99M |